- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Sustained Release Ocular Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Sustained Release Ocular Drug Delivery Systems market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cataract accounting for % of the Sustained Release Ocular Drug Delivery Systems global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liposome segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sustained Release Ocular Drug Delivery Systems include pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, and Neurotech Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sustained Release Ocular Drug Delivery Systems market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposome
Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Implants
Market segment by Application can be divided into
Cataract
Glaucoma
Corneal Transplantation
Others
The key market players for global Sustained Release Ocular Drug Delivery Systems market are listed below:
pSivida
Allergan
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc.
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sustained Release Ocular Drug Delivery Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sustained Release Ocular Drug Delivery Systems, with price, sales, revenue and global market share of Sustained Release Ocular Drug Delivery Systems from 2019 to 2022.
Chapter 3, the Sustained Release Ocular Drug Delivery Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sustained Release Ocular Drug Delivery Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sustained Release Ocular Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sustained Release Ocular Drug Delivery Systems.
Chapter 13, 14, and 15, to describe Sustained Release Ocular Drug Delivery Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Sustained Release Ocular Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sustained Release Ocular Drug Delivery Systems Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liposome
1.2.3 Microcapsules/Nanocapsules
1.2.4 Microspheres/Nanosptheres
1.2.5 Implants
1.3 Market Analysis by Application
1.3.1 Overview: Global Sustained Release Ocular Drug Delivery Systems Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cataract
1.3.3 Glaucoma
1.3.4 Corneal Transplantation
1.3.5 Others
1.4 Global Sustained Release Ocular Drug Delivery Systems Market Size & Forecast
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume (2017-2028)
1.4.3 Global Sustained Release Ocular Drug Delivery Systems Price (2017-2028)
1.5 Global Sustained Release Ocular Drug Delivery Systems Production Capacity Analysis
1.5.1 Global Sustained Release Ocular Drug Delivery Systems Total Production Capacity (2017-2028)
1.5.2 Global Sustained Release Ocular Drug Delivery Systems Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sustained Release Ocular Drug Delivery Systems Market Drivers
1.6.2 Sustained Release Ocular Drug Delivery Systems Market Restraints
1.6.3 Sustained Release Ocular Drug Delivery Systems Trends Analysis
2 Manufacturers Profiles
2.1 pSivida
2.1.1 pSivida Details
2.1.2 pSivida Major Business
2.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Product and Services
2.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Product and Services
2.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Icon Bioscience
2.3.1 Icon Bioscience Details
2.3.2 Icon Bioscience Major Business
2.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product and Services
2.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ocular Therapeutix
2.4.1 Ocular Therapeutix Details
2.4.2 Ocular Therapeutix Major Business
2.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product and Services
2.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Neurotech Pharmaceuticals
2.5.1 Neurotech Pharmaceuticals Details
2.5.2 Neurotech Pharmaceuticals Major Business
2.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Services
2.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Santen Pharmaceutical
2.6.1 Santen Pharmaceutical Details
2.6.2 Santen Pharmaceutical Major Business
2.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product and Services
2.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Aciont Inc.
2.7.1 Aciont Inc. Details
2.7.2 Aciont Inc. Major Business
2.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product and Services
2.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Envisia Therapeutics
2.8.1 Envisia Therapeutics Details
2.8.2 Envisia Therapeutics Major Business
2.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product and Services
2.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GrayBug
2.9.1 GrayBug Details
2.9.2 GrayBug Major Business
2.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Product and Services
2.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Innocore Pharmaceuticals
2.10.1 Innocore Pharmaceuticals Details
2.10.2 Innocore Pharmaceuticals Major Business
2.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Services
2.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 OHR Pharmaceuticals
2.11.1 OHR Pharmaceuticals Details
2.11.2 OHR Pharmaceuticals Major Business
2.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Services
2.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 PolyActiva
2.12.1 PolyActiva Details
2.12.2 PolyActiva Major Business
2.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Product and Services
2.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 TheraKine
2.13.1 TheraKine Details
2.13.2 TheraKine Major Business
2.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Product and Services
2.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sustained Release Ocular Drug Delivery Systems Breakdown Data by Manufacturer
3.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sustained Release Ocular Drug Delivery Systems
3.4 Market Concentration Rate
3.4.1 Top 3 Sustained Release Ocular Drug Delivery Systems Manufacturer Market Share in 2021
3.4.2 Top 6 Sustained Release Ocular Drug Delivery Systems Manufacturer Market Share in 2021
3.5 Global Sustained Release Ocular Drug Delivery Systems Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sustained Release Ocular Drug Delivery Systems Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Region
4.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2017-2028)
4.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2028)
4.2 North America Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028)
4.3 Europe Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028)
4.4 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028)
4.5 South America Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028)
4.6 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Type (2017-2028)
5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2028)
5.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Application (2017-2028)
6.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2028)
6.3 Global Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
7.2 North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
7.3 North America Sustained Release Ocular Drug Delivery Systems Market Size by Country
7.3.1 North America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028)
7.3.2 North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
8.2 Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
8.3 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Country
8.3.1 Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028)
8.3.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
9.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
9.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size by Region
9.3.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
10.2 South America Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
10.3 South America Sustained Release Ocular Drug Delivery Systems Market Size by Country
10.3.1 South America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028)
10.3.2 South America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
11.2 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
11.3 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Market Size by Country
11.3.1 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sustained Release Ocular Drug Delivery Systems and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sustained Release Ocular Drug Delivery Systems
12.3 Sustained Release Ocular Drug Delivery Systems Production Process
12.4 Sustained Release Ocular Drug Delivery Systems Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sustained Release Ocular Drug Delivery Systems Typical Distributors
13.3 Sustained Release Ocular Drug Delivery Systems Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. pSivida Basic Information, Manufacturing Base and Competitors
Table 4. pSivida Major Business
Table 5. pSivida Sustained Release Ocular Drug Delivery Systems Product and Services
Table 6. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Sustained Release Ocular Drug Delivery Systems Product and Services
Table 10. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Icon Bioscience Basic Information, Manufacturing Base and Competitors
Table 12. Icon Bioscience Major Business
Table 13. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product and Services
Table 14. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Ocular Therapeutix Basic Information, Manufacturing Base and Competitors
Table 16. Ocular Therapeutix Major Business
Table 17. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product and Services
Table 18. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Neurotech Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Neurotech Pharmaceuticals Major Business
Table 21. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Services
Table 22. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Santen Pharmaceutical Major Business
Table 25. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product and Services
Table 26. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Aciont Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Aciont Inc. Major Business
Table 29. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product and Services
Table 30. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Envisia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Envisia Therapeutics Major Business
Table 33. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product and Services
Table 34. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GrayBug Basic Information, Manufacturing Base and Competitors
Table 36. GrayBug Major Business
Table 37. GrayBug Sustained Release Ocular Drug Delivery Systems Product and Services
Table 38. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Innocore Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Innocore Pharmaceuticals Major Business
Table 41. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Services
Table 42. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. OHR Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. OHR Pharmaceuticals Major Business
Table 45. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Services
Table 46. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. PolyActiva Basic Information, Manufacturing Base and Competitors
Table 48. PolyActiva Major Business
Table 49. PolyActiva Sustained Release Ocular Drug Delivery Systems Product and Services
Table 50. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. TheraKine Basic Information, Manufacturing Base and Competitors
Table 52. TheraKine Major Business
Table 53. TheraKine Sustained Release Ocular Drug Delivery Systems Product and Services
Table 54. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 56. Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Sustained Release Ocular Drug Delivery Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Sustained Release Ocular Drug Delivery Systems Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 59. Head Office and Sustained Release Ocular Drug Delivery Systems Production Site of Key Manufacturer
Table 60. Sustained Release Ocular Drug Delivery Systems New Entrant and Capacity Expansion Plans
Table 61. Sustained Release Ocular Drug Delivery Systems Mergers & Acquisitions in the Past Five Years
Table 62. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2022) & (K Pcs)
Table 63. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2023-2028) & (K Pcs)
Table 64. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 67. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 68. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2022) & (USD/Pcs)
Table 71. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2023-2028) & (USD/Pcs)
Table 72. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 73. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 74. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2022) & (USD/Pcs)
Table 77. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2023-2028) & (USD/Pcs)
Table 78. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)
Table 79. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2023-2028) & (K Pcs)
Table 80. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 83. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 84. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 85. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 86. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)
Table 87. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2023-2028) & (K Pcs)
Table 88. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 91. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 92. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 93. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 94. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2022) & (K Pcs)
Table 95. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2023-2028) & (K Pcs)
Table 96. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 99. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 100. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 101. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 102. South America Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)
Table 103. South America Sustained Release Ocular Drug Delivery Systems Sales by Country (2023-2028) & (K Pcs)
Table 104. South America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 107. South America Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 108. South America Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 109. South America Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 110. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2022) & (K Pcs)
Table 111. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Region (2023-2028) & (K Pcs)
Table 112. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 115. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 116. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 117. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 118. Sustained Release Ocular Drug Delivery Systems Raw Material
Table 119. Key Manufacturers of Sustained Release Ocular Drug Delivery Systems Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Sustained Release Ocular Drug Delivery Systems Typical Distributors
Table 123. Sustained Release Ocular Drug Delivery Systems Typical Customers
List of Figures
Figure 1. Sustained Release Ocular Drug Delivery Systems Picture
Figure 2. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type in 2021
Figure 3. Liposome
Figure 4. Microcapsules/Nanocapsules
Figure 5. Microspheres/Nanosptheres
Figure 6. Implants
Figure 7. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application in 2021
Figure 8. Cataract
Figure 9. Glaucoma
Figure 10. Corneal Transplantation
Figure 11. Others
Figure 12. Global Sustained Release Ocular Drug Delivery Systems Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 13. Global Sustained Release Ocular Drug Delivery Systems Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Sustained Release Ocular Drug Delivery Systems Sales (2017-2028) & (K Pcs)
Figure 15. Global Sustained Release Ocular Drug Delivery Systems Price (2017-2028) & (USD/Pcs)
Figure 16. Global Sustained Release Ocular Drug Delivery Systems Production Capacity (2017-2028) & (K Pcs)
Figure 17. Global Sustained Release Ocular Drug Delivery Systems Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Sustained Release Ocular Drug Delivery Systems Market Drivers
Figure 19. Sustained Release Ocular Drug Delivery Systems Market Restraints
Figure 20. Sustained Release Ocular Drug Delivery Systems Market Trends
Figure 21. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturer in 2021
Figure 22. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturer in 2021
Figure 23. Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Sustained Release Ocular Drug Delivery Systems Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Sustained Release Ocular Drug Delivery Systems Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2017-2028)
Figure 27. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2017-2028)
Figure 28. North America Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028) & (USD Million)
Figure 29. Europe Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028) & (USD Million)
Figure 31. South America Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue (2017-2028) & (USD Million)
Figure 33. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 34. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2017-2028)
Figure 35. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2028) & (USD/Pcs)
Figure 36. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 37. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2017-2028)
Figure 38. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2028) & (USD/Pcs)
Figure 39. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 40. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 41. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2017-2028)
Figure 42. North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2017-2028)
Figure 43. United States Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 47. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 48. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2017-2028)
Figure 49. Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2017-2028)
Figure 50. Germany Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2017-2028)
Figure 59. China Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 66. South America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 67. South America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2017-2028)
Figure 68. South America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Sustained Release Ocular Drug Delivery Systems in 2021
Figure 80. Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
Figure 81. Sustained Release Ocular Drug Delivery Systems Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
